Soligenix (SNGX) Total Current Liabilities (2010 - 2026)

Soligenix's (SNGX) quarterly Total Current Liabilities came in at $3.6 million in Q1 2026, down 2.16% on a QoQ basis from $3.7 million in Q4 2025.

Soligenix (SNGX) Total Current Liabilities (2010 - 2026) Analysis & Trends

Soligenix (SNGX) has 17 years of Total Current Liabilities data on file, last reported at $3.6 million in Q1 2026.

Quarterly Total Current Liabilities changed N/A year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (changed N/A YoY) and the FY2025 annual result came in at $3.7 million, down 23.7% from the prior year.
Total Current Liabilities retreated to $3.6 million in Q1 2026, from $3.7 million in the prior quarter.
In the past five years, Total Current Liabilities ranged from a high of $16.5 million in Q4 2022 to a low of $3.4 million in Q3 2025.
A 5-year average of $6.8 million and a median of $6.0 million in 2023 frame the typical range for Total Current Liabilities.
Annual changes were most pronounced in 2022 — Total Current Liabilities soared 162.54% — and 2023, when it sank 62.75%.
Tracing SNGX's Total Current Liabilities over 5 years: stood at $16.5 million in 2022, then slumped by 62.75% to $6.2 million in 2023, then dropped by 21.19% to $4.8 million in 2024, then dropped by 23.7% to $3.7 million in 2025, then declined by 2.16% to $3.6 million in 2026.
The last three Total Current Liabilities figures came in at $3.6 million (Q1 2026), $3.7 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Current Liabilities (Qtr)
1	Vertex Pharmaceuticals	139.29 Bn	131.44 Bn	2.84 Bn	3.94 Bn
2	Regeneron Pharmaceuticals	86.31 Bn	78.32 Bn	3.93 Bn	5.53 Bn
3	Argenx Se	65.22 Bn	60.03 Bn	1.37 Bn	1.58 Bn
4	Moderna	58.92 Bn	53.78 Bn	52.00 Mn	2.53 Bn
5	BeOne Medicines	42.07 Bn	36.97 Bn	1.53 Bn	2.12 Bn
6	Alnylam Pharmaceuticals	31.70 Bn	28.39 Bn	992.69 Mn	1.51 Bn
7	BioNTech SE	27.99 Bn	9.60 Bn	668.28 Mn	2.49 Bn
8	Insmed	27.51 Bn	26.35 Bn	358.27 Mn	438.74 Mn
9	Royalty Pharma	27.28 Bn	26.45 Bn	-	630.93 Mn
10	Soligenix	6.34 Mn	6.34 Mn	-	3.67 Mn

Download Data